142 related articles for article (PubMed ID: 10880206)
1. Solution-phase synthesis of diaryl selenides using polymer-supported borohydride.
Millois C; Diaz P
Org Lett; 2000 Jun; 2(12):1705-8. PubMed ID: 10880206
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel retinoid X receptor-selective retinoids.
Faul MM; Ratz AM; Sullivan KA; Trankle WG; Winneroski LL
J Org Chem; 2001 Aug; 66(17):5772-82. PubMed ID: 11511251
[TBL] [Abstract][Full Text] [Related]
3. Selective RXR modulators for the treatment of type II diabetes.
Faul MM; Grese TA
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in receptor-selective retinoids.
Nagpal S; Chandraratna RA
Curr Pharm Des; 2000 Jun; 6(9):919-31. PubMed ID: 10828316
[TBL] [Abstract][Full Text] [Related]
5. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase synthesis of diaryl sulfides: direct coupling of solid-supported aryl halides with thiols using an insoluble polymer-supported reagent.
Gendre F; Yang M; Diaz P
Org Lett; 2005 Jun; 7(13):2719-22. PubMed ID: 15957930
[TBL] [Abstract][Full Text] [Related]
7. Copper oxide nanoparticle-catalyzed coupling of diaryl diselenide with aryl halides under ligand-free conditions.
Reddy VP; Kumar AV; Swapna K; Rao KR
Org Lett; 2009 Feb; 11(4):951-3. PubMed ID: 19182886
[TBL] [Abstract][Full Text] [Related]
8. Unexpected C-Se cross-coupling reaction: copper oxide catalyzed synthesis of symmetrical diaryl selenides via cascade reaction of selenourea with aryl halides/boronic acids.
Reddy VP; Kumar AV; Rao KR
J Org Chem; 2010 Dec; 75(24):8720-3. PubMed ID: 21090802
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.
Vuligonda V; Garst ME; Chandraratna RA
Bioorg Med Chem Lett; 1999 Feb; 9(4):589-94. PubMed ID: 10098670
[TBL] [Abstract][Full Text] [Related]
10. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
11. 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists.
Dawson MI; Jong L; Hobbs PD; Xiao D; Feng KC; Chao WR; Pan C; Fontana JA; Zhang XK
Bioorg Med Chem Lett; 2000 Jun; 10(12):1311-3. PubMed ID: 10890153
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.
Amano Y; Noguchi M; Nakagomi M; Muratake H; Fukasawa H; Shudo K
Bioorg Med Chem; 2013 Jul; 21(14):4342-50. PubMed ID: 23685180
[TBL] [Abstract][Full Text] [Related]
13. sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor (RXR) selectivity.
Dawson MI; Hobbs PD; Jong L; Xiao D; Chao WR; Pan C; Zhang XK
Bioorg Med Chem Lett; 2000 Jun; 10(12):1307-10. PubMed ID: 10890152
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the structure-activity relationship of retinoids--Hansch analysis and 3D-OSAR studies on specific ligands of retinoid x receptor].
Huang N; Chu F; Guo Z
Yao Xue Xue Bao; 1998 Jun; 33(6):442-8. PubMed ID: 12016914
[TBL] [Abstract][Full Text] [Related]
15. Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.
Jong L; Lehmann JM; Hobbs PD; Harlev E; Huffman JC; Pfahl M; Dawson MI
J Med Chem; 1993 Sep; 36(18):2605-13. PubMed ID: 8410972
[TBL] [Abstract][Full Text] [Related]
16. Identification of the first retinoid X, receptor homodimer antagonist.
Canan Koch SS; Dardashti LJ; Hebert JJ; White SK; Croston GE; Flatten KS; Heyman RA; Nadzan AM
J Med Chem; 1996 Aug; 39(17):3229-34. PubMed ID: 8765503
[No Abstract] [Full Text] [Related]
17. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
[TBL] [Abstract][Full Text] [Related]
18. Links between pharmacological properties of retinoids and nuclear retinoid receptors.
Bollag W; Isnardi L; Jablonska S; Klaus M; Majewski S; Pirson W; Toma S
Int J Cancer; 1997 Feb; 70(4):470-2. PubMed ID: 9033657
[No Abstract] [Full Text] [Related]
19. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
20. Novel retinoids with receptor selectivity and functional selectivity.
Johnson A; Chandraratna RA
Br J Dermatol; 1999 Apr; 140 Suppl 54():12-7. PubMed ID: 10731129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
